Bleeding as a Sentinel Event in New Malignancy Diagnoses Across Diverse Indications for Oral Anticoagulant Use: A Real-World Cohort, Nested Case-Control and Target Trial Emulation Study — Zuo Qi (2025) | RDL Network
Bleeding as a Sentinel Event in New Malignancy Diagnoses Across Diverse Indications for Oral Anticoagulant Use: A Real-World Cohort, Nested Case-Control and Target Trial Emulation Study
Yang‐Chieh Brian Chen, Chih‐Sung Liang, Liang‐Jen Wang, Kuo‐Chuan Hung, André F. Carvalho, Marco Solmi, Eduard Vieta, Ping‐Tao Tseng, Pao‐Yen Lin, Yu‐Kang Tu, Chih‐Wei Hsu, Edward Chia‐Cheng Lai
Ghislaine Scélo, David C. Muller, Elio Riboli, Mattias Johansson, Amanda J. Cross, Paolo Vineis, Konstantinos K. Tsilidis, Paul Brennan, Heiner Boeing, Petra H.M. Peeters, Roel Vermeulen, Kim Overvad, H. Bas Bueno-de-Mesquita, Gianluca Severi, Vittorio Perduca, Marina Kvaskoff, Antonia Trichopoulou, Carlo La Vecchia, Anna Karakatsani, Domenico Palli, Sabina Sieri, Salvatore Panico,
Elom K. Aglago, Sabina Rinaldi, Heinz Freisling, Li Jiao, David J. Hughes, Veronika Fedirko, Casper G. Schalkwijk, Elisabete Weiderpass, Christina C. Dahm, Kim Overvad, Anne Kirstine Eriksen, Cecilie Kyrø, Marie‐Christine Boutron‐Ruault, Joseph A. Rothwell, Gianluca Severi, Verena Katzke, Tilman Kühn, Matthias B. Schulze, Krasimira Aleksandrova, Giovanna Masala, Vittorio Krogh, Salvatore Panico,
Discussion(0)
No comments yet. Be the first to comment.